SAN DIEGO, May 7, 2018 /PRNewswire/ -- Neurana Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the treatment of neuromuscular conditions, announced the completion of a $60 million Series A
Growth Capitalist (https://growthcapitalist.com/2018/05/neurana-pharmaceuticals-announces-completion-of-60-million-series-a-financing/)
SAN DIEGO, May 7, 2018 /PRNewswire/ -- Neurana Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the treatment of neuromuscular conditions, announced the completion of a $60 million Series A